Related Experiment Video
Updated: Jul 18, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Phaeochromocytoma--views on current management
D T Williams1, S Dann, M H Wheeler
1Department of Endocrine Surgery, University Hospital of Wales, Heath Park, CF14 4XW, Cardiff, UK.
Summary
Surgical excision of phaeochromocytoma offers a high cure rate for hypertension with zero mortality. Adequate preoperative management and a multidisciplinary approach are crucial for optimal outcomes, especially in complex familial or multiple tumor cases.
Area of Science:
- Endocrinology
- Surgical Oncology
- Nephrology
Background:
- Phaeochromocytoma, a rare neuroendocrine tumor, often presents with hypertension.
- Effective management requires accurate diagnosis, localization, and surgical intervention.
Purpose of the Study:
- To evaluate the diagnostic and management strategies for phaeochromocytoma.
- To assess surgical outcomes and identify challenges in patient care.
Main Methods:
- Retrospective analysis of 47 patients undergoing surgical excision of phaeochromocytoma.
- Utilized urinary catecholamines for diagnosis and imaging (CT, MRI, MIBG) for localization.
- Preoperative management included alpha-adrenergic blockade with phenoxybenzamine and beta-blockers.
Main Results:
- Hypertension was the most common presentation (70%).
- CT and MRI were the most sensitive localization tools.
- Zero 30-day postoperative mortality with 21.3% complication rate.
- 80% of patients were cured of hypertension.
- Cortex-sparing procedures were unsuccessful for familial or multiple tumors.
Conclusions:
- Surgical excision of phaeochromocytoma is safe and effective, leading to high hypertension cure rates.
- Preoperative pharmacological control and a multidisciplinary approach are essential.
- Laparoscopic techniques are increasingly utilized; familial and multiple tumors present management challenges.
Related Concept Videos
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...